Anna Rosell Novel Graduated in Biology (2001) and PhD in Medicine (2005), both at Universitat Autònoma de Barcelona. My scientific education and expertise has been focused in the translational study of stroke disease and therapies. I obtained a Miguel Servet research position in 2010 from the Spanish National Institute of Health and Research Agency (Instituto Carlos III), and since February 2016 I hold a Tenure position at VHIR as Principal Investigator and Head of the Neurovascular Research Laboratory. Institutions of which they are part Head of group Neurovascular Diseases Vall Hebron Institut de Recerca Email Anna Rosell Novel Email Institutions of which they are part Head of group Neurovascular Diseases Vall Hebron Institut de Recerca Graduated in Biology (2001) and PhD in Medicine (2005), both at Universitat Autònoma de Barcelona. My scientific education and expertise has been focused in the translational study of stroke disease and therapies. I obtained a Miguel Servet research position in 2010 from the Spanish National Institute of Health and Research Agency (Instituto Carlos III), and since February 2016 I hold a Tenure position at VHIR as Principal Investigator and Head of the Neurovascular Research Laboratory.
As a PhD student at Vall d’Hebron Research Institute (VHIR) I was trained in the biomarkers field and clinical stroke studies, which gave me a solid understanding of the disease from a clinical perspective. After I moved to the United States for a Postdoctoral position at the Massachusetts General Hospital in a world-leading laboratory recognized for their experimental studies in cerebral ischemia (Neuroprotection Research Laboratory-MGH), which offered me the opportunity to extend my experience at a more basic and experimental level. I obtained a Miguel Servet position in 2010 from the Spanish National Institute of Health and Research Agency (Instituto Carlos III), and since February 2016 I hold a Tenure position at VHIR as Principal Investigator and since 2017 I am the head of the Neurovascular Research Laboratory. The main focus of my research is the search of new therapies for stroke patients based on neurorepair strategies with specific emphasis on the role of angio-vasculogenesis using nanomedicine and cell-therapy approaches for regenerative medicine. This has allowed me to obtain independent funding as PI from national agencies, Euronanomed program and private foundations, to supervise and guide PhD Students, Post-doctoral researchers, and establish national and International collaborations with other PIs in the neuroscience, regenerative medicine and nanotechnology fields. I do have the research accreditation of Associate Professor from AQU. My group has a distinction of Consolidated Research Group by AGAUR (2017SGR 1427) and belongs to the Spanish Cooperative Network for Research in Cerebrovascular Diseases (RICORS-2022).
Projects MAGBBRIS: New MAGnetic Biomaterials for Brain Repair and Imaging after Stroke IP: Anna Rosell Novel Collaborators: Maria Pilar Delgado Martínez, Guillem Colell Dinares, Miguel García Gabilondo Funding agency: Instituto de Salud Carlos III Funding: 149919 Reference: AC17/00004/MAGBBRIS Duration: 01/01/2018 - 30/04/2021 Sol·licitud PFIS IP: Anna Rosell Novel Collaborators: Laia Perez Lasarte Funding agency: Instituto de Salud Carlos III Funding: 82400 Reference: FI17/00073 Duration: 08/01/2018 - 07/06/2022 Incorporació Dr. Joan Montaner a la RETICS en Malalties vasculars cerebrals (ICTUS) IP: - Collaborators: Anna Rosell Novel, Mercedes Arrúe Gonzalo, Marcel Lamana Vallverdu, Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, Maria Pilar Delgado Martínez, Guillem Colell Dinares, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel, Anna Rosell Novel Funding agency: Instituto de Salud Carlos III Funding: 240669 Reference: RD16/0019/0021 Duration: 01/01/2017 - 31/12/2021 SMARRTS-II- Marcadores de Angiogenesis y Reparación durante Terapia rehabilitadora tras el ictus: Estudio clínico multicéntrico y modelo animal de neurorehabilitación en ratón. IP: Anna Rosell Novel Collaborators: Susana Rodriguez Gonzalez, María Inmaculada Bori de Fortuny, Xavier Buxo Masip, Laura Mónica Perez Bazan, Marco Inzitari Funding agency: Instituto de Salud Carlos III Funding: 116765 Reference: PI16/00981 Duration: 01/01/2017 - 31/12/2019 Pagination First page « Previous page ‹ … Page 3 Page 4 Current page 5 Page 6 Page 7 … Next page › Last page »
